Literature DB >> 20383727

Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet's disease.

N Şule Yaşar1, Füsun Salgür, Döndü Ü Cansu, Timuçin Kaşifoğlu, Cengiz Korkmaz.   

Abstract

This retrospective study aims to seek a relationship between the number of thrombotic events and presence of thrombophilic factors in Behcet's disease (BD). Any patient with a vascular problem evaluated for at least one thrombophilic factor was deemed eligible for the present study. Upon an evaluation of their medical records, 96 (23.9%) of the 402 patients diagnosed with BD were determined to have a history of thrombosis. Of these 96 patients, 72 (75%) had only one thrombotic attack, while the remaining 24 (25%) had two or more thrombotic attacks. Thrombophilic parameters were evaluated in only 36 of the 72 patients (50%) who had one thrombotic event (Group I) and in 18 of the 24 patients (75%) who had more than one thrombotic event (Group II). The patients with recurrent thrombotic events had a significantly higher incidence of combined thrombophilias than those patients with only one thrombotic event (8/18, 44%; 4/36, 11%; p < 0.01). The number of the patients free from thrombophilic risk factors was significantly higher in Group I than in Group II (21/36, 58%; 4/18, 22%; p < 0.02). Group II had an increased frequency of combined thrombophilic risk factors (OR 6.4; 95% CI 1.5-25.8) when compared to Group I. No significant differences were found between Groups I and II with respect to clinical features of BD. In conclusion, combined thrombophilias in patients with BD may have a role in the development of recurrent thrombotic events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383727     DOI: 10.1007/s10067-010-1455-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

Review 1.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

2.  Is anticoagulation unnecessary in Behcet's disease with deep venous thrombosis?

Authors:  Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2007-12-08       Impact factor: 2.980

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Protein C and protein S activities in Behçet's disease as risk factors of thrombosis.

Authors:  N Lenk; G Ozet; N Alli; O Coban; S Erbaşi
Journal:  Int J Dermatol       Date:  1998-02       Impact factor: 2.736

5.  Factor V Leiden mutation in patients with Behçet's disease.

Authors:  A F Oner; A Gürgey; A Gürler; L Mesci
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

6.  The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

Authors:  V De Stefano; I Martinelli; P M Mannucci; K Paciaroni; P Chiusolo; I Casorelli; E Rossi; G Leone
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

7.  Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.

Authors:  P B Toydemir; A H Elhan; A Tükün; R Toydemir; A Gürler; A Tüzüner; I Bökesoy
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

8.  Coagulation parameters and plasma total homocysteine levels in Behcet's disease.

Authors:  Yun Jong Lee; Seong Wook Kang; Jong In Yang; Young-Mi Choi; Donghyuk Sheen; Eun Bong Lee; Sang-Woon Choi; Yeong Wook Song
Journal:  Thromb Res       Date:  2002-04-01       Impact factor: 3.944

9.  Cerebral venous thrombosis in Behçet's disease.

Authors:  D Saadoun; B Wechsler; M Resche-Rigon; S Trad; D Le Thi Huong; A Sbai; D Dormont; Z Amoura; P Cacoub; J C Piette
Journal:  Arthritis Rheum       Date:  2009-04-15

Review 10.  Behçet's syndrome.

Authors:  Sebahattin Yurdakul; Hasan Yazici
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-10       Impact factor: 4.098

View more
  3 in total

1.  Serum vitronectin levels in patients with Behçet's disease.

Authors:  Ali Yalçındağ; Aslıhan Uzun; F Nilüfer Yalçındağ; Namık Delibaş
Journal:  Inflamm Res       Date:  2012-07-19       Impact factor: 4.575

2.  Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.

Authors:  M B Owlia; G Mehrpoor
Journal:  ISRN Pharmacol       Date:  2012-03-08

3.  Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses.

Authors:  Fatma Alibaz-Oner; Asl Karadeniz; Sema Ylmaz; Ayşe Balkarl; Gezmiş Kimyon; Ayten Yazc; Muhammet Çnar; Sedat Ylmaz; Fatih Yldz; Şule Yaşar Bilge; Emre Bilgin; Belkis Nihan Coskun; Ahmet Omma; Gözde Yldrm Çetin; Yonca Çağatay; Yaşar Karaaslan; Mehmet Sayarlioğlu; Yavuz Pehlivan; Umut Kalyoncu; Ömer Karadağ; Timuçin Kaşifoğlu; Eren Erken; Salih Pay; Ayşe Çefle; Bünyamin Kisacik; Ahmet Mesut Onat; Veli Çobankara; Haner Direskeneli
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.